Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is I3 Capital Group's primary focus as an investor?
- I3 Capital Group, formerly Arcstone Israel, is a division of a US FINRA and Canadian Exempt Market Dealer focused on providing Institutional quality Merchant, Investment Banking, and Equity Research Services to Israeli Private and Public Market companies. They assist Israeli growth companies in accessing North American capital markets.
- When was I3 Capital Group founded?
- I3 Capital Group was founded in 2024.
- What was a notable investment made by I3 Capital Group?
- In July 2025, I3 Capital Group made a lead investment of $1.5 million in VVT Medical, a company in the Health Tech & Life Sciences sector.
- Has I3 Capital Group had any exits from its portfolio companies?
- Yes, I3 Capital Group had an exit in July 2025 when its portfolio company, VVT Medical, underwent a Reverse Merger Event with DXI Capital Corp. and was listed on the TSXV.
- What is I3 Capital Group's sector concentration based on its investment activity?
- According to startupim data, I3 Capital Group's investment activity shows a concentration in the Health Tech & Life Sciences sector, with its sole recorded investment and exit in this area.
- What type of advisory services does I3 Capital Group offer to Israeli companies?
- I3 Capital Group offers advisory services for investor marketing, fundraising, IPOs, mergers, and cross-border opportunities to help Israeli growth companies access North American capital markets.
- Where are I3 Capital Group's main offices located?
- I3 Capital Group has offices in Dallas, USA, and Vaughan, Canada.
- What is I3 Capital Group's role in supporting companies using Canadian stock exchanges?
- As part of a US and Canadian financial group, I3 Capital Group supports companies in using Canadian stock exchanges as a launchpad before expanding to the US.